Matches in SemOpenAlex for { <https://semopenalex.org/work/W2563028535> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W2563028535 abstract "Abstract Abstract 3994 Myeloma cells can harbor ∼ 35 mutations, whereas according to Loeb's model, if > 2 oncogenic mutations are required for the development of a malignancy, then an elevation in the mutation rate would be required for these mutations to occur in the same cell. Indeed, there is evidence that hypermutability in myeloma may be a result of abnormal homologous recombination or activation induced cytidine deaminase. An alternative model is that successive rounds of clonal selection in an expanding pre-malignant population could result in an accumulation of oncogenic mutations. Using our method for the detection of rare cells that have an acquired somatic mutation of the PIG-A gene, we have previously demonstrated hypermutability in some but not all lymphoma and myeloma cell lines, and we have recently shown that samples of ex vivo blasts from ∼ 50% of patients with ALL demonstrate hypermutability. Here we have hypothesized that genomic instability could be identified in myeloma. PIG-A encodes an enzyme that is necessary for the biosynthesis of glycosylphosphatidylinositol (GPI) and is particularly promising as a sentinel gene for spontaneous mutations because it is X-linked, and thus a single mutation can produce the mutant phenotype. PIG-A is mutated in Paroxysmal Nocturnal Hemoglobinuria (PNH), and it is known from this condition that a broad spectrum of inactivating mutations can produce the PNH phenotype, which is a loss of all GPI-linked surface proteins. PIG-A mutations do not affect transmembrane proteins and are growth-neutral under almost all circumstances. The PNH phenotype can be readily detected by flow cytometry, using antibodies specific for GPI-linked proteins (e.g., CD48, CD55, and CD59), as well the FLAER reagent, which binds directly to GPI. In order to quantitate the frequency of myeloma cells with the PNH phenotype, we analyzed thawed ficolled samples from patients with a heavy burden of myeloma cells in the marrow. Cells were stained sequentially with FLAER-Alexa 488, then with a mixture of murine anti-CD48, anti-CD55, and anti-CD59 antibodies, followed by FITC-conjugated rabbit anti-mouse immunoglobulin, followed by a PE-conjugated antibody specific for a myeloma-specific transmembrane protein–either CD38 or CD138. Live myeloma cells were identified by forward/side scatter and propidium iodide exclusion and expression of CD38 or CD138. Using this approach, in previous studies we have seen that cells with the PNH phenotype have a low FITC/FLAER fluorescence, defined as < 4% of the level of the GPI (+) cell population, after gating for cells with at least 10% of the PE fluorescence of the GPI (+) population. For a negative control, we analyzed 2 non-malignant B-lymphoblastoid cell lines (BLCLs) from normal donors, and for a positive control, we analyzed the mantle cell lymphoma cell line HBL2A (in this case using CD45-PE to identify transmembrane proteins). The normal BLCLs demonstrated a frequency of PNH cells of 6.3 × 10−6 and 18.4 × 10−6, which is in the range that we have previously reported for BLCLs and granulocytes from normal individuals. These values are also similar to the frequency of spontaneously arising phenotypic variants in normal donors using other genes. In contrast, as we have previously reported, the mantle cell line demonstrated a markedly higher frequency of cells with the PNH phenotype– 1034 × 10−6. Of the involved marrow samples analyzed, there were at least 2 distinct groups. One group, representing 14 of the 20 samples (70%), demonstrated a mutant frequency that is comparable to non-malignant cell populations, with a median value of 9.5 × 10−6 (range 2.4 to 37 × 10−6). The remaining 6 samples (30%) demonstrated a markedly increased frequency of PNH cells, with a median value of 90 × 10−6 (range 73 to 11,763 × 10−6). Most of the samples analyzed were obtained from patients who had received prior therapy, but one of the samples demonstrating a very high frequency of PNH cells (1314 × 10−6) was derived from a patient who had not had prior therapy and was known to have had an abnormality of p53 based on FISH. This data demonstrates that an increase in inactivating mutations—as determined by this assay– is not essential for the development of myeloma, but it does seem to be a common feature of this condition. This flow-based assay could be applied at the time of diagnosis to facilitate investigations as to whether hypermutability correlates with outcome in patients with myeloma. Disclosures: No relevant conflicts of interest to declare." @default.
- W2563028535 created "2017-01-06" @default.
- W2563028535 creator A5014513613 @default.
- W2563028535 creator A5021241213 @default.
- W2563028535 creator A5023745355 @default.
- W2563028535 creator A5032212629 @default.
- W2563028535 creator A5042372543 @default.
- W2563028535 creator A5043653013 @default.
- W2563028535 creator A5085532598 @default.
- W2563028535 date "2012-11-16" @default.
- W2563028535 modified "2023-09-27" @default.
- W2563028535 title "Identification of Ex Vivo Myeloma Cells with the PNH Phenotype" @default.
- W2563028535 doi "https://doi.org/10.1182/blood.v120.21.3994.3994" @default.
- W2563028535 hasPublicationYear "2012" @default.
- W2563028535 type Work @default.
- W2563028535 sameAs 2563028535 @default.
- W2563028535 citedByCount "0" @default.
- W2563028535 crossrefType "journal-article" @default.
- W2563028535 hasAuthorship W2563028535A5014513613 @default.
- W2563028535 hasAuthorship W2563028535A5021241213 @default.
- W2563028535 hasAuthorship W2563028535A5023745355 @default.
- W2563028535 hasAuthorship W2563028535A5032212629 @default.
- W2563028535 hasAuthorship W2563028535A5042372543 @default.
- W2563028535 hasAuthorship W2563028535A5043653013 @default.
- W2563028535 hasAuthorship W2563028535A5085532598 @default.
- W2563028535 hasConcept C104317684 @default.
- W2563028535 hasConcept C113968399 @default.
- W2563028535 hasConcept C127716648 @default.
- W2563028535 hasConcept C13514818 @default.
- W2563028535 hasConcept C153911025 @default.
- W2563028535 hasConcept C207001950 @default.
- W2563028535 hasConcept C26291073 @default.
- W2563028535 hasConcept C2908647359 @default.
- W2563028535 hasConcept C501734568 @default.
- W2563028535 hasConcept C502942594 @default.
- W2563028535 hasConcept C54355233 @default.
- W2563028535 hasConcept C71924100 @default.
- W2563028535 hasConcept C86803240 @default.
- W2563028535 hasConcept C99454951 @default.
- W2563028535 hasConceptScore W2563028535C104317684 @default.
- W2563028535 hasConceptScore W2563028535C113968399 @default.
- W2563028535 hasConceptScore W2563028535C127716648 @default.
- W2563028535 hasConceptScore W2563028535C13514818 @default.
- W2563028535 hasConceptScore W2563028535C153911025 @default.
- W2563028535 hasConceptScore W2563028535C207001950 @default.
- W2563028535 hasConceptScore W2563028535C26291073 @default.
- W2563028535 hasConceptScore W2563028535C2908647359 @default.
- W2563028535 hasConceptScore W2563028535C501734568 @default.
- W2563028535 hasConceptScore W2563028535C502942594 @default.
- W2563028535 hasConceptScore W2563028535C54355233 @default.
- W2563028535 hasConceptScore W2563028535C71924100 @default.
- W2563028535 hasConceptScore W2563028535C86803240 @default.
- W2563028535 hasConceptScore W2563028535C99454951 @default.
- W2563028535 hasLocation W25630285351 @default.
- W2563028535 hasOpenAccess W2563028535 @default.
- W2563028535 hasPrimaryLocation W25630285351 @default.
- W2563028535 hasRelatedWork W125570897 @default.
- W2563028535 hasRelatedWork W1974084408 @default.
- W2563028535 hasRelatedWork W1974559436 @default.
- W2563028535 hasRelatedWork W1996186788 @default.
- W2563028535 hasRelatedWork W2008360827 @default.
- W2563028535 hasRelatedWork W2024002630 @default.
- W2563028535 hasRelatedWork W2064208882 @default.
- W2563028535 hasRelatedWork W2345727083 @default.
- W2563028535 hasRelatedWork W2411495263 @default.
- W2563028535 hasRelatedWork W2468998928 @default.
- W2563028535 hasRelatedWork W2548700245 @default.
- W2563028535 hasRelatedWork W2551919214 @default.
- W2563028535 hasRelatedWork W2551985214 @default.
- W2563028535 hasRelatedWork W2579490146 @default.
- W2563028535 hasRelatedWork W2584745109 @default.
- W2563028535 hasRelatedWork W2586154980 @default.
- W2563028535 hasRelatedWork W2586505061 @default.
- W2563028535 hasRelatedWork W2600861628 @default.
- W2563028535 hasRelatedWork W2943634664 @default.
- W2563028535 hasRelatedWork W2994159050 @default.
- W2563028535 isParatext "false" @default.
- W2563028535 isRetracted "false" @default.
- W2563028535 magId "2563028535" @default.
- W2563028535 workType "article" @default.